ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 190 filers reported holding IMMUNOGEN INC in Q2 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.0%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q2 2020$3,125,000
+48.4%
679,401
+10.0%
0.01%0.0%
Q1 2020$2,106,000
+69.7%
617,689
+154.0%
0.01%
+100.0%
Q4 2019$1,241,000
-82.9%
243,150
-64.8%
0.00%
-82.4%
Q1 2018$7,263,000
+332.6%
690,445
+163.6%
0.02%
+325.0%
Q4 2017$1,679,000
-73.2%
261,942
-68.0%
0.00%
-76.5%
Q3 2017$6,255,000
+6032.4%
817,616
+5577.9%
0.02%
Q2 2017$102,00014,4000.00%
Other shareholders
IMMUNOGEN INC shareholders Q2 2020
NameSharesValueWeighting ↓
Redmile Group, LLC 3,984,734$15,421,0001.00%
Moloney Securities Asset Management, LLC 274,450$1,062,0000.55%
Schonfeld Strategic Advisors LLC 1,025,176$3,968,0000.40%
Orbimed Advisors 6,095,647$23,590,0000.27%
TWIN FOCUS CAPITAL PARTNERS, LLC 113,216$438,0000.26%
PINNACLE ASSOCIATES LTD 1,589,959$6,153,0000.12%
Baker Brothers Advisors 3,015,353$11,669,0000.10%
BAXTER BROS INC 58,000$224,0000.07%
SIMON QUICK ADVISORS, LLC 25,000$97,0000.06%
ClearBridge Investments 14,428,856$55,840,0000.06%
View complete list of IMMUNOGEN INC shareholders